Dow Down 0.01% Nasdaq Down 0.13%

CTI BioPharma Corp. (CTIC)

-NasdaqCM
2.58 Up 0.03(1.18%) 3:30PM EDT - Nasdaq Real Time Price
Prev Close:2.55
Open:2.57
Bid:2.56 x 9000
Ask:2.57 x 8000
1y Target Est:4.90
Beta:1.64
Earnings Date:Oct 28 - Nov 3 (Est.)
Day's Range:2.55 - 2.60
52wk Range:1.07 - 4.25
Volume:475,994
Avg Vol (3m):1,491,590
Market Cap:372.69M
P/E (ttm):N/A
EPS (ttm):-0.48
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CTIC

Comparison

Symbol% ChgMkt Cap
CTICUp 1.18%372.69M
BMYDown 1.09%83.25B
RHHBYUp 0.22%249.30B
SNYUp 0.72%144.82B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):10.23
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.61
Quarterly EPS Est (Sep-14) :-0.04
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

CTI BioPharma Corp., a biopharmaceutical company, is engaged in the acquisition, development, and commercialization of treatments for cancer. It primarily focuses on the commercialization of PIXUVRI, an aza-anthracenedione derivative, which is in ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback